Christoph L. Zollikofer, Erich Salomonowitz,
MD MD
a Francesco Antonucci, Gerd Stuckmann, MD
a
MD #{149} Ion
#{149} Markus Pfyffer, MD Largiad#{232}r, MD #{149} Anton
Arterial Stent Placement with Use of the Wallstent: Midterm of Clinical Experience’ Self-expandable stents of the Wallstent type were used in 26 iliac and 15 femoropopliteal artery lesions of 31 patients to treat stenoses or occlusions. The indications were confined to complex lesions, including residual stenoses and dissections after percutaneous procedures or previous surgery in the iliac artery lesions, and long-segment (mean, 13.5 cm) occlusions with inadequate response to percutaneous recanalization in the femoropopliteal artery lesions. In the iliac artery group, after stent placement, 96% of the lesions were patent at a mean followup of 16 months (range, 6-30 months). In the femoropopliteal artery group, of 11 patients available for follow-up, only six had patent stents at 7-26 months (mean, 20 months). Four of these six patients required one to three secondary interventions. Self-expanding endoprostheses are of great value in complex iliac artery lesions where simpie balloon dilation is insufficient. Stent placement for long femoral artery lesions should be performed with utmost reserve, and the extent of stent placement should be as short as possible. Index
terms:
grafts
and
stenosis ies,
Arteries, prostheses
femoral a
iliac
92.458,
984.458
angioplasty.
Arteriosclerosis,
92.721
Radiology
1991;
92.128,
#{149} Arteries,
984.128
or mecanabized
From
the
ES.,
Surgery
Departments
multifactomial and includes elastic vessel recoil, flow obstruction due to intimal flaps or residual wall imregulamities, intimal hyperplasia, and fibrous scar formation. Therefore, an
expandable endovascualr stent deemed useful for eliminating ondamy shown
recurrences previously
tonsspital
Medicine
Kantonsspital 15,
8401
Winterthur,
(C.L.Z.,
(M.P.),
Frauenfeld,
and
Winterthur, Switzerland;
of Surgery, University Hospital, and Department of Surgery,
Frauenfeld,
quests
accepted
January
to C.L.Z. RSNA,
1991
Figure 1. lam braided bility
is sec-
(Wallstent;
Medinvent,
Switzerland)
4. Address
reprint
re-
tubuflexi-
demonstrated.
AND
membrane
with
stent
and
membrane
2).
While
steel
rolled,
occlu-
diameter)
woven
form a tubular the filaments
nal
filaments
endoprosthesis
and axis
the stent, reduced,
highly (Fig
flexible
1). By
its diameter which allows
by
means
to
ph-
in the
moderately
longitudielongating
can be substantially mounting of the
stent on a special catheter for tion into the vascular system. The stent is constrained on catheter
pattern
The cmosspoints of soldered, rendering self-expandable,
of a doubled-over
un-
radially
because
for
12-
and
guide
14-mm
stent
wire and/or
low the
was
than
after PTA
mechanical of the dis-
of the stent, the ends of the stent in
enough vessel
were
or
mecanalization
evidence quate sure than
of the
placed
lumen, gradients 20 mm
the 20%-40%
(dediameter
to be
10%-18%
native
artery
after
of extensive
lead
length The
pressure by wall to prevent
Stents ses
chosen
that
stents,
The introducing a conventional
constrained state are marked by markers (Fig 2). During deployment, stent shortens by approximately
(0.10-mm
(Fig
is being
sizes up to 10 mm, the introducis placed with use of a 7-F hesheath;
greater
op-
matericatheter
of the filavessel curvature.
of its original constrained pending on stent diameter).
in a crisscross
braid. are not
expands
eased artery. For exact placement proximal and distal
METHODS
the
friction
membrane
the stent
stent system
by
of contrast between
spring characteristics and adapts to the
0.035-inch recanalization
iliac
of surgical-grade
alloy
is retracted
to eliminate
the
mostatic
and
consists
that
a 9-F sheath is required. catheter is placed over
Lausanne, artery
ing
For ing
been
in 31 patients
and/or femoropopliteal sive disease.
able,
Switzerland
expanded stent. The with its longitudinal
erator during injection a! into the virtual space
of the ments
We report our midterm results with a self-expandable metallic stent
the Kan-
Fully mesh
is well
of the
(IL.). From the 1990 RSNA scientific assembly. Received September 24, 1990; revision requested November 12; revision received January 2, 1991;
as has (7-12).
Stent Characteristics Placement
of Radiology
Internal
(AM.),
Department Zurich (FR.);
me-
179:449-456
CS.),
Brauerstrasse
however,
cm in length, however, have a limited success rate of 50%-60% (3-6). The cause for long-term failure of PTA is
stainless I
amtemies,
main a bothersome problem. Short segmental stenoses of iliac and femoropopliteal arteries have a high patency rate after PTA. Long irregular stenoses or occlusions of more than 3
The
F.A.,
a
transluminal angioplasty (PTA), local thrombolysis, and aspiration thromboembolectomy have replaced surgical interventions in many instances, with significant savings in cost and loss of productivity, and with lower morbidity and mortality rates (1,2). Restenosis and occlusion of dilated
a
, 984.721
VMD
ERCUTANEOUS
MATERIALS
#{149} Arter-
Redha, MD
Marty,
Results
Arteries,
Arteries,
or obstruction,
transluminal
a
P
#{149} Falah
the stent migration. PTA
to a!-
against
of steno-
of occlusions
with
dissection
or made-
or
in cases of residual presacross the lesions of more Hg. The different indications
introducthe
delivery roll-
Abbreviation: minal
PTA
=
percutaneous
translu-
angioplasty.
449
a.
b.
C.
Figure
2. Release mechanism of the Wallstent. (a) The stent is mounted eate the proximal and distal ends of the constrained stent. Straight arrow holds the constrained stent on the catheter. Note the sliding side-arm port and sliding membrane. (b) By sliding back the side arm to which one end progressively unfolded, thereby releasing the stent. Note foreshortening rolled membrane. (C) The stent is fully released by complete retraction of The membrane is now completely rolled back (short arrow).
for stent placement Table 1 . Whenever
a stenosis
fully
stent
relieved
are
after
was performed in the the stent to accelerate sion
of the
summarized
on the introducing catheter. Two lead markers (arrowheads) delinindicates the distal end of the doubled-over rolling membrane that (curved arrow) for injection of contrast material between catheter of the rolling membrane is attached (long arrow), the membrane is of the stent. Short arrow indicates the distal end of the partly Unthe rolling membrane with the sliding side-arm port (long arrow).
in
was
not
placement,
segment maximum
PTA
containing expan-
stent.
Patients Thirty-one men)
patients
aged
50-83
(10
years
women,
21
(mean,
64 years)
received treatment for 41 arterial lesions (26 iliac, 15 femoropophiteal) with a total of 74 Wallstent endoprostheses measuring
5-12
mm
in
had previously In 80% of our vasive
studies
such
and
oscillometry
fore
stent
arteries
placement.
values rivatives, months agulation
performed
Most
patients
procedure,
infusion of per 24 hours,
the
patients
noninvasive
ed otherwise.
a
with
patients
15,000-20,000 IU until therapeutic
of
(Quick) test. anticoagulaof the pen-
and angiographic the clinical evaluation followed
means
up
62.5 stents
Radiology
patients
aged
years)
received
6-12
mm
lesions
in
and
of 18 patients a claudication
with
stage
hA,
two
50-77 diameter
for
24
occlusions.
stage
first stage
IIB),
Fifseen II (four
two
had
1st
3 6-12 was perindicat-
total
7.7
cm).
ac arteries, rent stenosis
and
patients had these patients lateral disease. femoropopliteal
Femoropopliteal
two or more lesions; three of received treatment for biIn one patient, bilateral stent placement had
performed stenotic
previously. segments
measured
1-20
the
two
occlusions
measured
2.5
en to cover
the
entire
lesion.
In one
pa-
tient, stents were placed in the entire iliac artery on one side (Fig 3). The lengths of the implanted stents varied from 30 to 70
all
but
arterial
seg-
3.5-20.0
two
radiation
cm
patients,
the
Arteries
(average, (76%)
claudication stage IlA, tients Only
had two
less. Seven superficial 3-17
four sions
cm had of
ili-
therapy.
Thirteen patients aged (mean, 74 years) received lesions consisting of three 12 occlusions, measuring tients
in length. For lesions more than 5 cm in length, up to three stents were placed in a tandem fashion and overlapped each oth-
of
was
another patient had recurof the external iliac artery
undergoing
length
cm
In
length
stents
stenoses were of an atherosclerotic natune. In one patient, stents were placed for tumorous compression from metastatic disease of the common and external
after
stent;
(ie, Doppler
the
containing
stage III, and one had stage IV. Twelve patients showed one stenotic lesion (eight common iliac and four external iliac). Six
The
again
and
(mean,
treatment
(83%) were Fontaine
1 1 with
years
cm, with an average length of 4.6 cm. Twenty-one of 26 lesions (80%) measured 5 cm or less and were treated with one
studies in
the
mm,
teen with
been
disease. were
pressures and oscillometry) within week after stent placement, every months for the 1st year, and every months thereafter. Angiography formed after 6-12 months unless
450
Arteries
ments
(mean,
obtained, with coumarin dewhich were continued for 6-12 unless contraindicated. Anticowas regularly monitored with a
of concomitant
with
Iliac
Eighteen
un-
were
odic angiologic as well as on The
be-
5,000 IU of hepamin; afterreceived an intravenous hepa-
partial thromboplastin time The decision to discontinue tion was based on the results
case
pressures
been
dilation of the diseased stent placement was per-
the
given they
rin drip heparin
patients
stenotic
formed. During
were ward,
All
as Doppler
had
balloon before
derwent
diameter.
undergone angiography. patients, additional nonin-
13.5 were
cm).
first
stage
patients femoral
III,
Ten
seen
Fontaine seven with occlusions
62-83 years treatment for stenoses and 3-23 cm in
stage stage and
one
measured
had artery
in length (mean, femoropopliteal 12-28 cm in length
of
15
13 pa-
a clinical II (three with JIB), two pawith
had
stage 3 cm
IV. or
occlusions of the that measured 8.7 cm), and artery occlu(mean, 18.2
May
1991
a.
b.
Figure PTA
on
3. Stage the left
by
previous
nal
iliac
iliac into sal
III claudication and had been performed
PTA
of
the
left
external
shows
decreased
artery. (c) After the external and
implantation common
of
arteries
claudication
a. Figure
to
bilateral previously.
stage
iliac flow
occlusion of the superficial (a) Pelvic arteriogram
(b) Control
artery. from
C.
extensive
pophiteal
junction
viously
and
unknown
after
placement
mm,
overlapping
ening
of
fect
adaptation
the
in
the
of
distal
and were
popliteal
an
left
artery of the
and
unrelieved
and three iliac artery
stenosis
overlapping lumen
in
the
stents bilaterally
proximal
right
external
6, 7, and 8 mm in diameter with rapid flow and never-
while
the
as well
aneurysm
Wallstent
compared
stent
artery
implanted
into with
knee
d.
man with recanahization
artery
8-mm
also
surface the
the
c. in a 67-year-old axis. (b) After pophiteal
of a 6-mm luminal
on
iliac
hA.
recanalized stents
dissections
of an 8-mm stent in the right external iliac arteries on the left, there is reconstitution
Radiographs obtained of the femoropopliteal
occlusion
angiogram
intimal
b. 4.
femoral arteries in a 67-year-old man. Surgical endarterectomy and shows severe diffuse bilateral disease with a dissected lumen caused obtained after PTA of the right external and left common and exter-
that
into in
the and the
occlusion
the
in d)
and
popliteal
the
Control
popliteal
femoral lateral
e.
history of claudication local thrombolysis and (c,
distal
distal b,
in
as an is shown.
the
is bent
1-month with
tibiofibular
trunk
angiograms
in
artery the
just
proximal
artery
projection.
(e)
stage IIB. PTA, there
proximal to
and
aneurysm
is partly
Overlapping
of
the
expanded
Note
the
25-cm femoro-
Also,
a pre-
projections
5 days
tnifurcation. There
stents
shows at the artery.
lateral
recanalized arteries.
thrombosed. fully
tibial and
now
popliteal
angiogram stenosis
anterior
anteropostenior
to the
middle
(a) Femoral is a persistent
Three
is marked
smooth-
flexibility
and
is shown
1 week
10per-
after
placement.
cm). Stent placement one patient for bilateral ral artery occlusions, current stenosis after
was
performed superficial in one patient PTA, and in
ditional patient for obstructing after thromboendanterectomy. tient, stents were viously undetected well as a residual
Volume
179
a
in femofor reone ad-
plaques In one
pa-
placed because of a prepopliteal aneurysm as superficial femoral an-
Number
2
teny
stenosis after a long-segment femoropopliteal artery recanalization (Fig 4). The segments containing stents measured 3-8 cm (mean, 5.5 cm) for the three stenoses, 23-32 cm (mean, 28 cm) for the eight superficial femoral artery occlusions, and 7-38 cm (mean, 25 cm) for the four
(three
femoropophiteal
measured
artery
more
than
occlusions
25 cm).
In
two
patients the stents crossed and in another two patients
the the
knee joint, stents
ended just proximal to the level of the joint space. The lengths of the implanted stents measured 30-80 mm, and the stent diameters varied from 5 to 12 mm. Apart from three patients with one stent each (23%), all other patients had two to six stents
placed
in
tandem
fashion
Radiology
and
over-
a
451
lapping
each
eased tients,
the
sclerotic
to cover
segments treated
origin,
to be or
other
arterial
performed
the
(Fig
lesions
were
and
stent
for
poor
entire
dis-
4). In all paof atheno-
placement result
Table 2 Clinical Results
after
Iliac
RESULTS
rized
in Tables
all but artery follow-up
After
two
and
stent stent
At latest
Stage
Time
I
hA
IIB
III
IV
0
4
11
2
1
15
3
0
0
0
15
2
0
0
0
Ankle/Arm Indexes
placement placement
follow-up
0.63
± 0.25 (15) 0.85 0.22 (15) 0.88 ± 0.22
Femoropophiteal Before
placement
stent
stent
At latest
All tame stage
patients with claudication stage II had improvement I; the three patients with
conversion ranged
with a mean from one acute
Fonto stage
to stage 6 to 30
from
NA 26 of 26 (100) 25 of 26
of 16 months. occlusion, 25 of
(96)
arteries1 0
3
7
2
1
8
0
3
1
0
5
1
0
0
0
0.61
± 0.15 (10) 0.89 ± 0.23 (10) 0.90 ± 0.10 (16)
2-4.
Arteries
Patency*
(15)
The patency rates groups are summa-
Iliac
months Apart
Stents
arteriest
Before
After
III and IV had IIA. Follow-up
Patent
Fontaine Site
after 6-30 months. of the two patient
with
PTA
recanalization.
Among the 31 patients, patients from the femoral group were available for
in Patients
had
placement follow-up
NA 15 of 15 (100) 7 of 13 (54)
Note.-Values for Fontaine stage are numbers of patients. Values for ankle/arm indexes are means 1 standard deviation (numbers of patients are in parentheses). Values for patency are numbers lesions (percentages are in parentheses). * NA = not applicable. t Number of patients, 18; number of lesions, 26; follow-up ranged from 6 to 30 months (mean, months). I Number of patients, 13; number of lesions, 15; follow-up ranged from 7 to 26 months (mean, months). One patient was lost to follow-up. One patient died after 3 months, with a patent stent.
±
of
16 20
26 arteries (96%) containing stents were patent without significant signs of mestenosis. our results
A detailed overview of is given in Tables 2 and 3.
Follow-up five patients
angiograms after 1 year
obtained showed
in
intimal
hyperplasia
main-
left
side after 4 months. Atherectomy and PTA were performed. The patient was free of symptoms 1 year later, and the foblow-up angiogram showed only
moderate intimal reaction. In another patient who bilateral
stent
calcified
iliac
had
ed PTA
not
was
fully
for
stenoses,
452
of a femoropophiteal as well as a stenosis
a
Radiology
Cause
19
Stent
Placement
Management
NA
NA
1
Decreased outflow
Surgical
2
Intimal
Outcome Patent at 6-30 mo (mean, 16 mo), no secondary
Thrombotic clusion wk
ocafter 2 steno=
4)
Note-Definite
hy-
occlusion
Intimal hyperplasia occurred
in one
ath-
erectomy PTA PTA
of 24 lesions
inter-
vention Stent occluded
bypass
Percutaneous
perplasia 2
8-
Repeat-
with
no resid-
ual pressure gradient after angioplasty and with clinical reversal to stage hA. No clinical on angiographic recurrence of stenosis was so far observed in any of the other patients with stents placed in iliac arteries (Tables 2, 3). However, one patient who underwent stent placement for postsurgical dissection of the external iliac artery and ipsilateral subtotal occlusion graft,
None
after
Lesions
Patent
at 28 mo
Patent
at 6 mo
and
(4%). NA
not applicable.
partly
the
expanded.
performed
of 24 Iliac Artery No. of Lesions
Complications
Recurrent sis (ii
mm stent had expanded to only 5 mm at the site of a localized stenosis on the might after 4 months. Because the patient was symptomatic again (stage IIB), angiography was performed and showed significant intimal hypemplasia at the area where the stent
of Follow-up
underwent
placement
artery
3
Results
a
thin layer of intimal proliferation covering the filaments in three patients. One patient with bilateral subtotal stenoses of the proximal common iliac artery had a recurrence due
to marked by on the
Table
bypass of the
deep
femoral
flow,
artery
suffered
causing
reduced
an acute
occlusion
out-
of
the segment containing the stent after one month. This occlusion occurmed before meoperation on the severely diseased femoral axis could be performed.
stage III and IV had conversion to stage I and IIB, respectively. In an other patient, recurrent early thrombotic occlusion after stent placement in a recanalized 17-cm-long superfiwith
cial femoral worsening
JIB. The Femoropopliteal Of the
12 patients
Arteries with
femorab
and femoropopliteal lesions available for follow-up immediately after stent placement, three did not have improvement. In one patient, stent placement could not completely eliminate poor runoff from a single stenotic vessel to the calf after dissection during recanalization. In two patients, the segments containing stents thrombosed in the 1st week. Seven patients had improvement from stage II to stage I; two patients
artery occlusion caused from clinical stage hA to
underlying
bly elevated never dropped range during
cause
was
proba-
fibrinogen levels, which to the therapeutic percutaneous throm-
bobysis. A detailed overview of the results are shown in Tables 2 and 4. There were another five thrombotic occlusions (Tables 2, 4). One early occlusion was successfully recanalized with percutaneous aspiration thrombectomy and PTA 2 weeks after stent placement returned after rent symptoms. showed severe (Fig 6a), which
(Fig 5). The patient 12 months with recurAngiography intimal hyperplasia again was treated
May
1991
a.
b.
Figure
5.
artery. partially
There is only the anterior patent lumen. (c) After
tery
Claudication
placed
proximally,
which
Table 4 Results of Follow-up
in
an
resulted
diabetic
in complete
of 14 Femoral No.
Thrombotic
occlusion (n = 4)
2 wk
Thrombotic
in
occlusion
woman.
after
(b)
(a)
Arteniogram
e.
shows
13-cm
occlusion
in
the
distal
superficial
femoral
recanalization with 200,000 IU of urokinase and PTA, there is only a of 6 and 7 mm in diameter, full patency of the superficial femoral anocclusion occurred. The stents are further expanded compared with those in c. clot aspiration was performed. and an additional overlapping 7-mm stent (arrows) restoration of the entire lumen. Patient’s claudication was relieved.
and Femoropoliteal
After stents
Artery
after
Lesions
Stent
Placement
of
Lesions
None
first
82-year-old
tibial artery as distal runoff. placement of three overlapping
Complication
d.
C.
IIB
(d) Two weeks later, acute thrombotic recanahization by means of percutaneous
is restored.
(e) Successful was
stage
Cause
Outcome
Management
4
NA
NA
1 1
Possible level Decreased
1 1t
Decreased Decreased
outflow inflow
I
Decreased
outflow
1
Anticoagulation stopped at 4 mo, cerebral hemorrhage, hemiparesis lntimal hyperplasia Progressive atherosclerosis, moderate intimal hyperplasia Intimal hyperplasia leading to occlusion
No
21
Intimal
hyperplasia
bilaterally
Bilateral
1
Intimal sive
hyperplasia, atherosclerosis
progres-
increased
fibninogen
outflow
at 2 mo
3 patent at 4 and 25 mo, no secondary intervention, I patent at 3 mo (patient died) Stent occluded
Percutaneous and surgical thrombectomy Percutaneous lysis and aspiration Surgical bypass Iliac stent placement and surgical thrombectomy
Stent occluded Patent after one repeated PTA for intimal hyperplasia at 18 mo
Surgical
Stent
occluded
Stent
occluded
bypass
Patent
after
second
repeated
PTA
2wk(n2)
Recurrent
(n
stenosis
6)
1 1 1
Note-Definite S
I
occlusion
occurred
in five
Two
complications
in the
same
patient.
Two
complications
in the
same
patient.
of 14 lesions
with PTA. After 9 months without symptoms, the patient again had to undergo treatment with PTA for mecurrent intimal hypemplasia (Fig 6b, 6c).
Six lesions oped
Volume
containing
recurrent
179
stenoses
a
Number
2
stents
devel-
in five
pa-
(36%).
therapy
PTA X 2 Percutaneous PTA No further
PTA
atherectomy
and
therapy
and
Fontaine
stage
I at 26
Patent,
Fontaine
stage
I at 26 mo
Stent
PTA
X 2, PTA
Patent,
atherectomy
occluded
mo
at 6 mo
Bilateral intimal
stents patent, hyperplasia,
stage Patent,
hA at 18 mo Fontaine stage
recurrent Fontaine
I at 15 mo
X 1 NA
not
applicable.
tients secondary to intimal hyperplasia or progression of atherosclerotic disease after 5-12 months. Two of these lesions were outside the area containing the stent. Five lesions in four patients underwent successful treatment with atherectomy and/or
repeated PTA. In the fifth patient, clusion developed after 6 months control, and any further intervention was denied (Table 4). Currently, six of the 1 1 patients available for long-term follow-up have patent stents at 7-26 months
Radiology
ocof
a
453
(mean, 20 months) the six underwent
(Table 4). Four of secondary inter-
ventions. Five patients have a claudication Fontaine stage I, and one has stage hA. Another patient died without symptoms 3 months after stent placement for a superficial femomab
artery occlusion. Follow-up angiography of nonmeoccluded femoropopliteal artery stents was performed in six patients more than 3 months after placement. Two had a recurrent stenosis outside the area containing the stent, with only (less
moderate than 40%
intimal of the
hyperplasia stent diameter)
within the stent. Two examined for recurrent ten
9 months
and
Angiography
patients were symptoms af-
1 year,
showed
respectively.
extensive
inti-
mal proliferation within the stents leading to mestenosis. Both under-
went
treatment
with
PTA
(Fig
6). The
second patient had to undergo treatment twice at intervals of 3 and 5 months; at the last treatment, pencutaneous athemectomy was performed in addition to PTA. In a patient with
a dilative form who underwent
of atherosclerosis, stent placement
obstructing surgical follow-up
stenoses and thromboendarterectomy, angiogmam at
showed
smoothening
a 1 year
previ-
Complications only
one
case
of
stent dislocation at the time of placement. In a short subtotal stenosis of the proximal common iliac artery, a stent of 3-cm length was squeezed
backward out of the stenosis and migrated 3 cm downstream. A second, 6-cm-long stent was then placed coaxially eming stent.
through the stenosis
In one
the
first, as well
instance,
problems releasing the rolling membrane completely retracted. released stent was
with
the
through
the
thereby as the
coyfirst
we experienced the
stent because could not be The partially retrieved together
introducing
instrument
check-flow
one patient, a groin oped that required
patient
as in Figure
5 shows
within
the
containing
(a) Follow-up segment
sheath.
In
hematoma devebsurgical evacua-
The main reasons for ten necanalization and/or mural thrombus formation
gressive
organization
454
a
Radiology
stent.
Patient
Two (Tables
were 3, 4).
mestenoses afPTA are with pro-
and
perplasia by myofibroblasts Both factors are related injury may flaps,
wall
irregularities
causing
tion
or turbulence
of flow.
(6) and
Kaufman
intimal
hy-
(13-18). to the con-
trolled vessel wall angioplasty, which clefts, obstructing
induced at produce and marked
et al (19)
obstrucCobapinto
have
dem-
onstrated that the rate of restenosis is significantly higher with a residual pressure gradient of 15 mm Hg on more. A higher patency rate with a smooth luminal surface after PTA
was
shown
by Van
Intraluminal should compensate
stent
Andel
et al (20).
placement the mechanical
wall damage induced at PTA. a! stenosis may be eliminated
wall,
placement.
the
1 year after with multiple
hyperplasia
DISCUSSION
al) after
necanalized
intimal
One patient had an acute cerebral hemorrhage with hemiparesis after 4 months. Anticoagubation had to be discontinued, and occlusion of the previously open femoropopliteal axis (Fig 4) occurred 2 weeks later.
expansile force of the regularities, particularly flaps, eccentric plaques, thrombus, are pushed
stent
severe
C.
obtained was
mildly
stent placement in same localized stenoses
symptomatic
(stage
IIA).
PTA
was repeated, and patient was again asymptomatic. (b) Arteniogram obtained another year later (2 years after stent placement) again shows intimal reaction but of a much lesser degree compared with that in a. Patient again had claudication stage IIA. (C) After repeated PTA, the lumen was much improved, and the patient became asymptomatic. Note that the collaterals are still patent within the segment containing the stent.
tion. There was acute thrombotic occlusion in the first 2 weeks in five besions (one iliac, four femoropoplitesuccessfully
b. arteriograms
femoral
after
ously irregular arterial wall with moderate intimal hyperplasia in the two segments of the superficial femonab artery and popliteal artery contaming stents (Fig 7).
We experienced
6.
for
flaps
of the
a. Figure
The
resulting favorable
hemodynamic
develop,
lumen. and
causing
nestenosis.
In spite
of concomitant femoral and/or liteal artery stenosis or occlusion the ipsibatemal side in six patients, which was subsequently treated
popon in
three, theme was substantial improvement in clinical stages and ankbe/ arm pressure indexes (Table 2). The indications for iliac artery stent placement can therefore be handled more liberally compared with those for femomopoliteal artery stent placement. Even in cases of long segmental lesions and extensive dissections, stents can be implanted successfully before surgical intervention . Procedure-related complications
are Residuby the
stent. Wall inobstructing or organized against the
in a smooth
clinical results in the iliac artery group with a patency rate of 96% aften 6 months to 21/2 years demonstrate the value of placing vascular stents in complex iliac artery lesions. Most of our patients would otherwise have been candidates for surgery. In contrast to the femorab artery group, only one thrombotic occlusion was observed and in only two patients did significant intimal hyperplasia
not
higher
when
compared
conventional PTA. The limited stent migration sequela and was treated ment of a second stent.
with
one case of had no direct with place-
Stent placement may also serve as a means for prevention of embolization during PTA in heavily ulcerated lesions. In two such cases, stents
May
1991
in most promised
of these outflow
patients, due
with to only
cornone or
two patent runoff arteries in the calf. In our patient population, however, we could not establish a definite relationship between tent runoff arteries
the
occlusion
that
smaller diameter of the arteries, compared
of the
consequential
iliac
factor.
coagulopathies
one
levels,
of our
patients,
b.
patient
Figure
7. IIA,
stage
In an surgical
5 months
previously.
stenosing
intimal
There
is occlusion
placement intimal the
flap, ends
stents tion
of of with
of
the
81-year-old man thromboendarterectomy (a) flaps of
an there
the
the
8-mm
only
is smoothening (c)
moderate
segments
in
of
intimal artery
shows at
trunk. the
(b)
popliteal relief
of
follow-up
Guenther et al (9), and Vorwerk and Guenther (10) with use of balloon-expandable Palmaz stents or the selfexpandable Wallstent. Nonetheless, until more and long-term results become available in sufficiently large series, we recommend stent placement in iliac arteries only for complicated lesions that do not respond well to PTA, in cases of iliac artery occlusion, or for obstructing lesions caused by prior surgery or PTA. The results of our femoropopliteal artery group are not as favorable as reported elsewhere (11,18). Also, the patient populations can hardly be compared, since we treated 13 occlusions, of which seven measured 10 cm on more, and only three stenoses. Such patients generally have not
179
a
Number
2
After the
of
PTA and
but stent
no
of
has
the the
previously
stent
tibial
to
stenotic shows
of
claudication been performed artery
anterior anterior
a 12-mm
signs
and had
axis
femoropopliteal
origin
arteniogram
reaction without
dilated the
artery
were inserted before balloon dilation. The stents were then balloon dibated secondarily for immediate full expansion. For the same reason, we underdilated considerably (with use of 4-5-mm-diameter balloons) after recanalization of an iliac artery occlusion with the guide wire. Only after stent placement (8-10-mm diameter) was the previous occlusion completely dilated to its full appropriate diameter. Similar results for iliac artery lesions were recently reported by Palmaz et al (8,21), Rees et al (7),
Volume
form of arteriosclerosis of the femoropophiteal
a stenosis
and
One-year
the
dilative
arteriogram and
tibiofibular stent
stents).
with
Femoral (arrows)
al patient
c.
tibial
artery
bridge
the
lesions
complete
recurrent
with artery.
stenosis.
and femoral
(arrows expansion Further
mark of
the
dila-
occurred.
been candidates for percutaneous necanalization. In addition, stent placement was performed only in cases in which conventional recanalization
by means
of guide
wines
aided
by
thrombolysis and subsequent balloon dilation did not produce satisfactory results and immediate or early reocclusion without stent placement would certainly have occurred. The relatively high rate of thrombotic occlusion and/or recurrent stenosis secondary to intimal hyperplasia (77%) remains a difficult problem to solve. Although 11 of 13 patients with femoropopliteal stents initially had improved hemodynamic and clinical stages, four patients had subsequent permanent occlusion, and four of six patients with currently patent stents needed one or more secondary interventions, either pencutaneous or surgical. The reasons can only be speculated. First, there was a high proportion of long segments with stents implanted compared with the results of other authors (11,18). In 10 patients, overlapping stents were placed tandemly for 20-38 cm to smoothe the entire diseased lumen. Thus, a significant amount of the arterial surface was exposed to foreign thrombogenic material. Second, there was diffuse disease
and
flow
its
seem
Furthermore, as elevated
as was
the
can
fi-
case
be the
in
cause
occlusion. Although our so far is limited to only
with
than 2 years cumrence (at a.
on
such
of an acute experience
one
arteries,
effects
an important bninogen
of paand
rate.
Third, the femoropopliteal
with
the number in the calf
a follow-up
of more
without significant methis writing an addition-
is at 5 months
after
stent
placement), patients with a dilative form of atherosclerosis, and therefore large-caliber peripheral arteries, may have better results than those with obliterating atherosclerosis. Finally, the significance of reduced inflow was clearly shown in a patient with acute occlusion after stent placement oven a 35-cm segment of superficial fernonal artery because of an additional iliac artery stenosis. The importance of the latter was underestimated at initial angiography. After relief of this inflow obstruction by means of PTA and stent placement, the superficial femoral artery memained open after surgical thrombectorny. The contralateral side with a 25-cm stented occlusion of the superficial fernoral artery produced no earby problems. Stent size is another factor that may influence intimab reaction. A mismatch of artery and stent diarneten by more than 20%, resulting in ovenexpansion of the arterial wall, may induce increased intirnal prolifenation (18,22,23). Furthermore, a mismatch between the transition of the artery containing the stent and the native artery may cause turbulence of flow and shearing forces that may again induce thrombosis or intimal hyperplasia. Therefore, correct sizing of the stent is essential and should be performed in analogy to PTA measurements of the diameter of the stenotic segment as well as of the diameter of the more or less normal adjacent artery. Because of the considerable rate of acute occlusions or restenoses associated with fernoropopliteal artery stent placement, patients must be fobbowed up closely to implement secondary interventions in due time.
Radiology
a
455
We have lysis tomy,
used
percutaneous
4.
fibmino-
and clot aspiration, and repeated PTA
atherecsuccessfully
in these patients. But again, recurrence of intimal thickening after mepeated PTA seems more likely in femomopopbiteab
pared
with
artery
lesions
lesions
com-
5.
iliac
amter-
be
more
suc-
Johnston study plasty.
ies. cessful intimal
might
than simple proliferation
because
of the
PTA for treating (24). However,
diffuse
disease
7.
and
possible compromise of blood flow by prolonged procedure time, we tend to treat long-segment restenoses
secondary only with Because
must
be
anticipated,
sions tion,
8.
only if mechanical including atherectomy
bogenic
9.
stent occlu10.
recanalizadevices
2.
stent placement in the shortpossible to reduce thromforeign-body surface. U
11.
12.
13.
Doubilet
14.
P. Abrams
angioplasty Zeitler Results
HL.
percutaneous for
N EngI
peripheral
I Med
E, Richter
Roth
of percutaneous
gioplasty.
JC,
Zeitler
Garcia
OJ,
Schatz
RA,
E,
stents
in
iliac
first
ology Vorwerk
1989;
172:725-730. D, Guenther
use
RW.
Radiology
cost
transluminal 1983;
of undis-
15.
310:95-102. FJ, Schoop 146:57-60.
#{149} Radiology
18.
171
iliac
of self-expandable
19.
W. an-
Sanborn
following
TA,
Weber
transluminal
proliferation stenosis
20.
of smooth for after
recurrent
Reste-
angioplasty
percutaneous
cells
coronary
5. Berlin:
of
perIn:
Heuck radiolo-
Springer-Verlag,
J, Mahler
Tnillen
1989;
1985;
F, Do D, et al.
Kaufman
SL, Barth
KH,
follow-up of the iliac
Radiology
1982;
Van
CJ,
Andel PJ.
Kadir
S, et al. in
long-term
1985;
156:325-328.
Palmaz
JC, Richter
Intraluminal
stents
727-731. Duprat C Jr.
the
evalan-
arteries.
142:329-336. Krepel
of the
Wallace
vasROnt-
of transluminal and femoral VM,
Van
Percutaneous
and
metallic mental
Die
femoro-popliFortschr
measurements
and
initial
21.
bei
150:88-94.
angioplasty
22.
VJ.
muscle
Vol
Breslau
arteries
in experimental atherosclerosis. Arteniosclerosis 1984; 4:189-195. Faxon DP, Sanborn TA, Haudenschild CC. Mechanism of angioplasty and its relation to restenosis. Am J Cardiol 1987; 60:5B-9B. Austin GE, Rathiff NB, Hollman J. Intimal explanation
basis angioplasty.
GM,
Radiology
Noeldge
C, et al.
in atherosclerotic
KC, C.
for
artery:
results.
Wright
stents
WFM,
femoropophiteal
S. Ciantunco evaluation.
Erp
transluminal
artery stenosis: preliminary multicenter study. Radiology
endoprosthe-
1984;
AL, Boijsen E, Fuchs WA, eds. Frontiers in European
uation gioplasty
iliac
report 1988;
of a 168:
Charnsangavej
C,
Self-expanding
small vessels: Radiology
expeni162:
1987;
469-472. 23.
Redha F, Zollikofer CL, Largiad#{232}r F. Experimental
of angioplasty
and
(abstr).
Presented
ropean
Society
logna. 24.
DP,
Experimental
Hemodynamic
pro-
ses. Radiology 1990; 175:411-415. Rousseau HP, Raillat CR, Joffre FG, Knight CJ, Ginestet MC. Treatment of femoropopliteal stenoses by means of selfexpandable endoprostheses: midterm resuIts. Radiology 1989; 172:961-964. Zollikofer CL, Largiader I, Brflhlmann WF, Uhlschmid GK, Marty AH. Endovascular stenting of veins and grafts: preliminary clinical experience. Radiology 1988; Faxon
transluminal
Radiology
kul#{228}re endoprothese tealer verschlusskrankheit.
Mechanical
of occluded
CL.
genstr
intralu-
arteries:
microscopy.
R,
evaluated
7 1-135.
202Anoc172:
E, Sibley
angioplasty
cutaneous
gy.
et al.
of balloon-expandable
coronary angioplasty. 1985; 6:369-375.
456
W,
Salomonowitz
Zollikofer
Baert FHW,
of iliac In: Dot-
cedures. Radiology 1990; 174:969-975. Guenther RW, Vorwerk D, Bohndonf K, Peters I, El-Din A, Messmer B. Iliac and femoral artery stenoses and occlusions: treatment with intravascular stents. Radi-
nosis
transluminal vascular
1984; El,
The
17.
angio-
167:707-712.
derutilization:
3.
Palmaz
with
Spence RK, Freiman DB, Gatenby R, et al. Long-term results of transluminal angioplasty of the iliac and femoral arteries. Arch Sung 1981; 116:1377-1386.
ease.
A, Schoop
revasculanization
References 1.
Gruntzig
CL,
Transluminal
electron 153:369-374.
SA,
transluminal 206:403-413.
1987;
Zollikofer
et al.
of a prospective
eds. Percutaneous transluminal angioplasty. Berlin: Springer-Verlag, 1983; 206. Rees CR, Palmaz JC, Garcia 0, et al. gioplasty and stenting of completely cluded iliac arteries. Radiology 1989;
minal
and catheter aspiration of clot matemial, does not provide an adequate lumen in patients who are poor surgical candidates. Furthermore, we now perform est length
CT,
16.
by
Hogg-Johnston
results
of percutaneous Ann Sung
Placement
we
think it is justified to perform placement for long-segment
M,
B. of
953-959.
to intimal hyperplasia simple PTA. multiple sessions to treat
recurrences
Rae
Five-year
Colapinto RF. Long-term results and femoropopliteal angioplasty. ten
Atherectomy
KW,
et al.
6.
in the
Gallino A, Mahler F, Probst P. Nachbur Percutaneous transluminal angioplasty the arteries of the lower limbs: a 5-year follow-up. Circulation 1984; 70:619-623.
May
Vorwerk intimal
Uhlschmid CK, combination
intraarterial at 23rd
for
stent
Congress
Surgical
of
Eu-
Research,
Bo-
Removal
of
1988. D, Guenther
hyperplasia
theses
by
tation.
AJR
artherectomy 1990;
RW. in vascular and
endoprosballoon
dila-
154:617-619.
as an artery
transluminal
J Am Coil
Cardiol
May
1991